Posted by noa on February 3, 2004, at 20:02:15
In reply to Re: Transdermal selegiline (EMSAM) marked approvable » noa, posted by Chairman_MAO on February 3, 2004, at 18:57:49
Yes, I just went back to read the release again--it is referring to post-marketing studies, as well as to some issues about labelling. But hopefully they are ok to go to market.
poster:noa
thread:308481
URL: http://www.dr-bob.org/babble/20040131/msgs/309062.html